Clinical Trial Update: Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating safety and efficacy of activated recombinant human factor VII in haemophilia patients with inhibitors undergoing and recovering …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Bleeding Disorder
• Haemophilia with Inhibitors

Drugs mentioned

• Activated Recombinant Human Factor VII (Factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Phase 4 | Status: COMPLETED